4-((R)-Hydroxy((1S,2S,4S,5R)-5-vinylquinuclidin-2-yl)methyl)quinolin-6-ol

Catalog No. :
ACVNSO305
CAS No. :
524-63-0
Molecular Formula :
C19H22N2O2
Molecular Weight :
310.40

IUPAC Name:4-((R)-hydroxy((1S,2S,4S,5R)-5-vinylquinuclidin-2-yl)methyl)quinolin-6-ol

4-((R)-Hydroxy((1S,2S,4S,5R)-5-vinylquinuclidin-2-yl)methyl)quinolin-6-ol structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g98%$59.00Login to see priceIn stockIn stock
5g98%$206.00Login to see priceIn stockIn stock
25g98%$824.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-((R)-Hydroxy((1S,2S,4S,5R)-5-vinylquinuclidin-2-yl)methyl)quinolin-6-ol
IUPAC Name4-((R)-hydroxy((1S,2S,4S,5R)-5-vinylquinuclidin-2-yl)methyl)quinolin-6-ol
MDL No.MFCD09842542
Molecular FormulaC19H22N2O2
Molecular Weight310.40
SMILESOC1=CC=C2N=CC=C([C@@H](O)[C@H]3[N@@]4C[C@H](C=C)[C@](CC4)([H])C3)C2=C1
InChI KeyVJFMSYZSFUWQPZ-BIPCEHGGSA-N
Synonymcupreine;(8,9R)-9-Diol Cinchonan-6 Cupreine;O-Demethylquinidine;O-Desmethyl Quinine;Ultraquinine;(8,9R)-9-Diol Cinchonan-6’;6'-hydroxycinchonidine;(8α,9R)-Cinchonan-6',9-diol
CAS No.524-63-0

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319
Precautionary Statement(s)
P264-P270-P280-P301+P312+P330-P302+P352+P332+P313+P362+P364-P305+P351+P338+P337+P313-P501

Synthetic Route by SureRoute

1. ACVNSO305 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACHSGN163 route compound structure diagram
    ACHSGN163130-89-2 In Stock
  2. Then
  3. ACVNSO305 route product structure diagram
    ACVNSO305524-63-0 In Stock
Inquiry

2. ACVNSO305 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACVNSO305 route product structure diagram
    ACVNSO305524-63-0 In Stock
Inquiry

Comments (0)